Shanghai Haohai Biological Technology Co., Ltd. (06826.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 16.54

From 52W high−46.29%

Volume337100.00

Market capHKD 3.43B

P/E (TTM)20.6x

P/S (TTM)1.3x

Div yield6.43%

Key dataSep 18, 2026

Open

HKD 16.54

From 52W high

−46.29%

Volume

337100.00

Market cap

HKD 3.43B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.9x

P/E (TTM)

20.6x

RSI (14)

27.4

MomentumView details →

1D Return

−5.65%

YTD Return

−37.70%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

20.6x

EV/EBITDA

5.9x

EV/Sales

0.5x

P/S (TTM)

1.3x

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

65.20%

Net Margin

6.24%

EBITDA Margin

8.17%

ROE (TTM)

2.74%

ROA (TTM)

2.21%

Asset Turnover

0.35x

GrowthView details →

Revenue YoY

−10.45%

EPS YoY

−57.14%

FCF YoY

−33.88%

Revenue CAGR 3Y

+5.16%

EPS CAGR 3Y

+1.27%

EBITDA YoY

−70.03%

MomentumView details →

1D Return

−5.65%

YTD Return

−37.70%

1Y Return

−42.94%

RSI (14)

27.4

vs 50D SMA

−7.67%

vs 200D SMA

−28.23%

Capital & dividendView details →

Debt/Equity

0.08x

Current Ratio

3.49x

Quick Ratio

2.95x

Div Yield

6.43%

Div Rate

HKD 0.98

Div Growth 1Y

−10.63%

EarningsView details →

EPS (Actual)

HKD 0.20

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.33B

Net Income (TTM)

145.24M

Op. CF (TTM)

498.64M

Next earningsOct 23, 2026 →

Latest newsMore news →

Shanghai Haohai Biological Technology Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 113 million yuan, down 46.64% year-on-year.30d ago

Shanghai Haohai Biological Technology Co., Ltd. announced a cash dividend of 2.5 yuan per 10 shares (tax inclusive), totaling 56.1875 million yuan (tax inclusive).30d ago

Similar companies

Legend Biotech CorporationLEGN 硕世生物688399.SH Viking Therapeutics, Inc.VKTX 普莱柯603566.SH 申联生物688098.SH Laekna, Inc.02105.HK Find similar companies →

Latest newsMore news →

Shanghai Haohai Biological Technology Co., Ltd. announced its first-half 2026 results: net profit attributable to shareholders was 113 million yuan, down 46.64% year-on-year.30d ago Shanghai Haohai Biological Technology Co., Ltd. announced a cash dividend of 2.5 yuan per 10 shares (tax inclusive), totaling 56.1875 million yuan (tax inclusive).30d ago